Evoke Pharma Cash Flow - Quarterly (NASDAQ:EVOK)

Add to My Stocks
$2.06 $0.09 (4.57%) EVOK stock closing price Mar 16, 2018 (Closing)

The Evoke Pharma cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about Evoke Pharma profits and Evoke Pharma debt. Evoke Pharma saw a cash impact of $7.38M from the issuance of EVOK shares. The cash flow statement helps in the Evoke Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. EVOK decrease in investments stood at a value of $- for the latest quarter 2017 Q3.

View and download details of Evoke Pharma cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities1.17M--0.17M--0.26M----
Cash From (used in) Discontinued Operations---------
Other Adjustments Net4.75M2.73M3.53M1.76M2.15M--1.54M1.16M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment---------
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares7.38M7.33M7.33M13.52M13.52M--5.03M4.62M
Issuance (Repayment) of Debt Securities----4.5M-4.5M----
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities---------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year8.69M14.15M24.19M--4.03M---
Cash & Equivalents at Year End10.41M12.55M14.65M9M10.37M4.12M6.09M8.69M10.73M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While Evoke Pharma stock price history provides the price history of a stock, Evoke Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Evoke Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Evoke Pharma stock price movement.
  • Cash Flow from operating activities: Evoke Pharma reported a negative operating cash flow of $-5.98M till 2017 Q3 and has seen a decrease from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $- for EVOK till last quarter 2017 Q3 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $7.38M for Evoke Pharma.

Key Financial Ratios For Evoke Pharma Cash Flow